Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.
Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
Key Takeaways The Stockholm3 blood test detects more prostate cancers than the standard PSA testThe test detects more ...
PROSTATE CANCER SCREENING initiated before 50 and with lower baseline prostate specific antigen (PSA) levels was associated ...
Add Yahoo as a preferred source to see more of our stories on Google. Researchers said the test could improve early detection while reducing unnecessary follow-up procedures. Stockholm3 is still ...
The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
A new study found the Stockholm3 blood test detected aggressive prostate cancer more accurately than the standard PSA test. Researchers said the test could improve early detection while reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results